🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial is studying the safety and efficacy of a personalized c...
Status
Recruiting
Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Start Date
2024-03-01
Trial ID
NCT07002203
Treatments Being Tested
The most important consideration in the design of this clinical trial is to...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-09-29
Trial ID
NCT02427581
Treatments Being Tested
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Effic...
Status
Enrolling By Invitation
Location
Precision NextGen Oncology & Research Center
Start Date
2022-11-30
Trial ID
NCT05741242
Treatments Being Tested
The purpose of this study is to determine the good and bad effects of atezo...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2019-05-08
Trial ID
NCT03359239
Treatments Being Tested
This is a phase 1 clinical trial to evaluate the safety, feasibility and im...
Status
Recruiting
Location
AdventHealth
Start Date
2025-03-20
Trial ID
NCT06529822
Treatments Being Tested
This is an intermediate patient expanded access protocol for treatment of p...
Status
Available
Location
Texas Oncology
Start Date
TBD
Trial ID
NCT06963697
Treatments Being Tested
The early clinical development paradigm for chemotherapeutic agents has sig...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-09-30
Trial ID
NCT03068832
Treatments Being Tested
The purpose of this study is to use precision medicine in the form of a vac...
Status
Active Not Recruiting
Location
Albert Einstein College of Medicine
Start Date
2018-03-01
Trial ID
NCT03223103
Treatments Being Tested
This is a Phase I, single-center, open-label, single-arm clinical trial to ...
Status
Not Yet Recruiting
Location
Peking University First Hospital
Start Date
2026-09-01
Trial ID
NCT07686744
Treatments Being Tested
This phase II trial studies how well nab-paclitaxel, durvalumab, and tremel...
Status
Recruiting
Location
UC Irvine Health/Chao Family Comprehensive Cancer Center
Start Date
2021-04-13
Trial ID
NCT03606967